Sign in

Niko Klink

@nikolasklink.bsky.social
373 followers 344 following 25 posts

Chemical Biology & drug discovery @Max Planck Dortmund | All things Ubiquitin and bifunctionals @Gersch Lab.

PostsRepliesMedia
Reposted by Niko Klink
Hellerschmied Lab @hellerschmiedlab.bsky.social · 15/07/2025
Very happy to see our contribution to a better understanding of Hsp70/90 #chaperones online! Congrats and a big thank you to all co-authors, collaborators and reviewers! #proteostasis @poepsel-lab.bsky.social @crc1430.bsky.social @unidue-zmb.bsky.social
13317
Niko Klink @nikolasklink.bsky.social · 05/07/2025
Really excited to share the first chapter of my PhD as a preprint titled: Targeted degradation of USP7 in solid cancer cells reveals disparate effects of deubiquitinase inhibition vs. acute protein depletion: www.biorxiv.org/content/10.1.... If that sounds interesting to you, small tweetorial below👇
biorxiv.org
Targeted degradation of USP7 in solid cancer cells reveals disparate effects of deubiquitinase inhibition vs. acute protein depletion
Proteolysis-targeting chimeras (PROTACs) co-op the ubiquitin system for targeted protein degradation, creating opportunities to interrogate cellular functions of proteins through "chemical knockdown"....
2152
Niko Klink @nikolasklink.bsky.social · 05/05/2025
Very excited to share that our work on Parkinson's target USP30 has been published in Nature Structural & Molecular Biology! By combining soluble DUB-domains onto USP30, we for the first time achieved co-crystallization with a small molecule (NK036) without Nanobodies! www.nature.com/articles/s41...
nature.com
Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30 - Nature Structural & Molecular Biology
Kazi et al. report the crystal structure of the mitochondrial deubiquitinase USP, a clinical stage Parkinson’s disease drug target, in complex with a specific inhibitor. The authors delineate a framew...
1110
Reposted by Niko Klink
Cynthia Wolberger @cwolberger.bsky.social · 21/03/2025
Wow. This is really stunning . www.science.org/doi/10.1126/...
science.org
In-cell architecture of the mitochondrial respiratory chain
Mitochondria regenerate adenosine triphosphate (ATP) through oxidative phosphorylation. This process is carried out by five membrane-bound complexes collectively known as the respiratory chain, workin...
1558
Reposted by Niko Klink
Mike Cohen @michaelnadbio.bsky.social · 25/02/2025
I'm super excited to share our study in collaboration with @jnpruneda.bsky.social, published today in @embojournal.org! We show that PARPs are modified with a non-canonical ester-linked mono-ADP-ribosylated ubiquitin species for the first time in cells: www.embopress.org/doi/full/10....
embopress.org
Ubiquitin is directly linked via an ester to protein-conjugated mono-ADP-ribose | The EMBO Journal
imageimageCertain E3 ligases have been found to ubiquitylate hydroxyl groups on free NAD+ and ADP-ribose in vitro, but the in vivo occurrence of this dual post-translational modification has remained ...
45020
Reposted by Niko Klink
Jakob Farnung @jakobfarnung.bsky.social · 29/01/2025
🎉Super excited to share our story on how the substrate receptor FBXO31 functions as a quality control factor by recognizing amides. This has been an amazing collaboration between Bode lab and @jcornlab.bsky.social. Special shutout goes to @matthiasmuhar.bsky.social www.nature.com/articles/s41...
nature.com
C-terminal amides mark proteins for degradation via SCF–FBXO31 - Nature
SCF–FBXO31 scans proteins for C-terminal amidation and marks them for subsequent proteasomal degradation.
38534
Niko Klink @nikolasklink.bsky.social · 25/11/2024
A fantastic story from our lab about finding novel activity in two "inactive" DUBs!
070
Niko Klink @nikolasklink.bsky.social · 15/11/2024
go.bsky.app/3VPQofn Great way to get started here!
031